TickerFactsScreenerDevelopers

ABVC BIOPHARMA, INC. (ABVC) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2010: $2.8K2011: $71.8K2012: $13.4K2013: $6182014: $02015: $994.8K2016: $18.6K2017: $93.3K2018: $226.7K2019: $144.3K2020: $4.27M2021: $5.83M2022: $85.3K2023: $60.2K2024: $248.4K2025: $681.5K$681.5K
2010Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$681.5K+174.4%
2024$248.4K+312.9%
2023$60.2K-29.4%
2022$85.3K-98.5%
2021$5.83M+36.4%
2020$4.27M+2861.4%
2019$144.3K-36.3%
2018$226.7K+142.9%
2017$93.3K+400.6%
2016$18.6K-98.1%
2015$994.8K—
2014$0-100.0%
2013$618-95.4%
2012$13.4K-81.4%
2011$71.8K+2451.0%
2010$2.8K—